but the reimbursement level in Germany isn't going to change any time in the foreseeable future for the reasons I mentioned, and the information you posted was 18 months old and we have a year of sales since that which has been reported and the stock price is 48c.
what do you mean. That statement is for 2014 and was made 18 months ago. Mandatory reimbursement (NUB Value 1) will only come with robust data, probably level 1 (randomised controlled clinical trial with survival stats). That will be years.